Considering the significant risk chikungunya poses to all individuals living in or traveling to endemic areas in 2025, authorizing a preventive vaccine for children has become essential as international tourism rebounds.
Currently, there are two chikungunya vaccines available in the United States; however, neither is approved for use in children.
Children Also Need Access to Chikungunya Vaccines
Widespread Decline Seen in MMR Vaccination Rates After COVID-19
Seventy-eight percent of 2,066 U.S. counties reported decline in coverage from prepandemic to postpandemic